查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829414

2025年全球生物晶片市场报告

Biochips Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，生物晶片市场规模快速扩张，从2024年的126.2亿美元成长到2025年的146.1亿美元，复合年增长率达15.7%。这段历史时期的成长可归因于个人化医疗需求的不断增长、慢性病的高发病率、技术创新、药物研发应用的不断扩展、研发投入的不断增加以及支持性法律规范的完善。

预计未来几年生物晶片市场规模将快速成长，到2029年将达到257.8亿美元，复合年增长率为15.2%。预测期内的成长机会可归因于照护现场应用的日益普及、药物开发应用的不断扩展、个人化医疗需求的不断增长、微流体技术的进步、研发投入的不断增加、生物技术公司与学术机构之间合作的不断加强，以及农业生物技术领域的新兴机会。预测期内的主要趋势包括：微流体技术的进步、对用于液态切片应用的生物晶片开发的日益重视、对用于同时检测多种分析物的多重检测的需求不断增长、人工智能在数据分析中的应用以及新型生物晶片平台的涌现。

生物晶片是一种微型装置，将DNA、蛋白质和细胞等生物材料附着在固体表面上。生物晶片将生物元件与电子系统结合，用于研究和操作生物数据，广泛应用于医疗诊断、基因序列测定和其他生物技术领域。

生物晶片的主要类型包括DNA晶片（或DNA微阵列）、蛋白质晶片、实验室晶片系统、组织阵列和细胞阵列。 DNA晶片利用微阵列和微射流等技术，能够同时分析大量基因的表现。这些生物晶片应用于药物研发、农业、基因组学、疾病诊断和蛋白质组学，并被各种终端用户使用，包括生物技术公司、製药公司、学术机构、医院和诊断中心。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供生物晶片市场统计数据，例如生物晶片行业的全球市场规模、各地区市场份额、各竞争对手的市场份额、详细的生物晶片细分市场、市场趋势和商业机会，以及您在生物晶片行业取得成功所需的数据。本生物晶片市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整观点。

我们预测未来五年该市场将成长15.2%，较先前预测略有下降1.1%。下降的主要原因是美国与其他国家之间关税的影响。这种影响可能会直接波及美国，导致来自台湾、韩国和日本等主要地区的高纯度硅片和微流体基板供应链中断，从而导致生产延迟以及基因组和诊断测试成本上升。此外，这种影响可能会透过互惠关税以及不断升级的贸易紧张局势和限制对全球经济和贸易的负面影响，更广泛地显现出来。

个人化医疗的日益普及预计将推动生物晶片市场的成长。个人化医疗旨在根据个人特征（例如遗传和生活习惯）客製化治疗方案，以优化疗效并最大程度地减少副作用。推动这一趋势的因素包括：个人化医疗有望提供更有效的治疗方案；基因组学的进步；疾病的日益复杂化；以及监管环境的变化。生物晶片在个人化医疗中发挥关键作用，它能够根据个人基因图谱制定精准的个人化治疗方案。例如，2024年2月，美国食品药物管理局（FDA）核准了16种针对罕见疾病的新型个人化疗法，凸显了个人化医疗的蓬勃发展动能及其对生物晶片市场的影响。

生物晶片市场的主要企业正专注于开发最尖端科技，例如器官晶片平台，以改变药物发现和开发流程。器官晶片平台是一种先进的微流体装置，旨在小规模模拟人体器官的生理特性和功能。例如，2024年4月，波士顿微製造公司（BMF）推出了BMF生物技术公司，专门研发用于试管内培养大规模组织的生物晶片和器官晶片平台。这项进展将透过提供体外测试和研究平台来加速药物和化妆品的开发。

2023年6月，朗道实验室收购了Cellix有限公司，增强了其在台式流式细胞技术领域的专业知识，并致力于改善个人化医疗和预防性医疗保健。此次收购扩展了朗道的产品组合，使更多研究人员和医疗保健专业人士能够使用流式细胞技术技术。总部位于爱尔兰的Cellix有限公司专注于为生命科学领域的各种应用开发生物晶片。

生物晶片市场包括实验室晶片(LOC) 设备、细胞微阵列和蛋白质微阵列的销售。该市场的价值指的是“出厂价”，即产品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球生物晶片：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球生物晶片市场：成长率分析
  • 全球生物晶片市场表现：规模与成长，2019-2024
  • 全球生物晶片市场预测：规模与成长，2024-2029年，2034年
  • 全球生物晶片：总目标市场（TAM）

第六章 市场细分

  • 全球生物晶片市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 去氧核糖核酸（DNA）晶片
  • 蛋白质晶片
  • 实验室晶片
  • 组织阵列
  • 细胞阵列
  • 全球生物晶片市场：按技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 微阵列
  • 微流体
  • 全球生物晶片市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 药物研发
  • 农业
  • 基因组学
  • 疾病诊断
  • 蛋白质体学
  • 其他用途
  • 全球生物晶片市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 生物技术和製药公司
  • 学术研究机构
  • 医院和诊断中心
  • 其他最终用户
  • 全球生物晶片市场：依去氧核糖核酸(DNA) 晶片类型细分，现况及预测，2019-2024 年、2024-2029 年、2034 年
  • 基因表现晶片
  • SNP（单核苷酸多态性）晶片
  • DNA微阵列
  • 全球生物晶片市场：蛋白质晶片细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 抗体阵列
  • 蛋白质微阵列
  • 胜肽阵列
  • 全球生物晶片市场：晶片实验室晶片（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 微流体设备
  • 生物感测器
  • 全球生物晶片市场：按组织阵列细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 肿瘤组织晶片
  • 正常组织阵列
  • 全球生物晶片市场：依细胞阵列类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 基于细胞的生物晶片
  • 细胞讯号传导阵列

第七章 区域和国家分析

  • 全球生物晶片市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球生物晶片市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 生物晶片市场：竞争格局
  • 生物晶片市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Tecan Group Ltd.
  • Cepheid Inc.
  • Randox Laboratories Ltd.
  • Takara Bio Inc.
  • Oxford Nanopore Technologies plc
  • Luminex Corporation
  • Fluidigm Corporation
  • Micronit Microtechnologies BV
  • Sphere Fluidics Limited
  • Sengenics
  • Arrayit Corporation
  • CustomArray Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年生物晶片市场：提供新机会的国家
  • 2029年生物晶片市场：细分市场带来新机会
  • 2029年生物晶片市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29592u

Biochips are compact devices containing an assortment of biological substances such as DNA, proteins, or cells, affixed onto a solid surface. They merge biological components with electronic systems for studying and manipulating biological data, finding extensive use in medical diagnostics, genetic sequencing, and other biotechnological domains.

The primary types of biochips include DNA chips (or DNA microarrays), protein chips, lab-on-chip systems, tissue arrays, and cell arrays. DNA chips allow the simultaneous analysis of numerous genes' expressions, leveraging technologies such as microarrays and microfluidics. These biochips find applications in drug discovery, agriculture, genomics, disease diagnostics, proteomics, and are utilized by diverse end users such as biotech firms, pharmaceutical companies, academic institutions, hospitals, and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The biochips market research report is one of a series of new reports from The Business Research Company that provides biochips market statistics, including biochips industry global market size, regional shares, competitors with a biochips market share, detailed biochips market segments, market trends and opportunities, and any further data you may need to thrive in the biochips industry. This biochips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biochips market size has grown rapidly in recent years. It will grow from $12.62 billion in 2024 to $14.61 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to increased demand for personalized medicine, high prevalence of chronic diseases, technological innovations, expanded applications in drug discovery, growth in investments in research and development, and supportive regulatory frameworks.

The biochips market size is expected to see rapid growth in the next few years. It will grow to $25.78 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to increasing adoption in point-of-care diagnostics, expanding applications in drug development, rising demand for personalized medicine, advancements in microfluidics technology, growing investments in research and development, expanding collaborations between biotechnology companies and academic institutions, and emerging opportunities in agricultural biotechnology. Major trends in the forecast period include advancements in microfluidics technology, emphasis on developing biochips for liquid biopsy applications, rising demand for multiplexed assays for simultaneous detection of multiple analytes, integration of artificial intelligence for data analysis, and the emergence of novel biochip platforms.

The forecast of 15.2% growth over the next five years reflects a modest reduction of 1.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for high-purity silicon wafers and microfluidic substrates, sourced from key regions such as Taiwan, South Korea, and Japan, which could lead to production delays and increased costs for genomic and diagnostic testing.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The biochips market is poised for growth due to the increasing adoption of personalized medicines. Personalized medicine involves tailoring medical treatments based on individual characteristics such as genetics or lifestyle, aiming to optimize effectiveness and minimize adverse effects. This trend is fueled by the potential of personalized medicine to offer more effective treatments, advancements in genomics, the rising complexity of diseases, and regulatory backing. Biochips play a crucial role in personalized medicine by enabling precise and individualized treatment plans based on a person's genetic profile. For instance, in February 2024, the FDA approved 16 novel personalized therapies for rare diseases in 2023, highlighting the momentum in personalized medicine adoption and its impact on the biochips market.

Leading companies in the biochips market are focusing on developing cutting-edge technologies such as organ-on-a-chip platforms to transform drug discovery and development processes. Organ-on-a-chip platforms are sophisticated microfluidic devices designed to mimic the physiological characteristics and functions of human organs on a smaller scale. For example, in April 2024, Boston Micro Fabrication (BMF) launched BMF Biotechnology Inc., specializing in biochips or organ-on-a-chip platforms for cultivating large-scale tissues in vitro. This advancement accelerates drug and cosmetic development by providing a testing and research platform outside the human body.

In June 2023, Randox Laboratories acquired Cellix Limited to bolster its expertise in benchtop flow cytometry, aligning with its commitment to personalized medicine and improved preventive healthcare. This acquisition expands Randox's portfolio and makes flow cytometry technology more accessible to a wider range of researchers and healthcare professionals. Cellix Limited, based in Ireland, specializes in creating biochips for various applications in the life sciences.

Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd, Zoetis Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

North America was the largest region in the biochips market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biochips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biochips market consists of sales of lab-on-a-chip (LOC) devices, cellular microarrays, and protein microarrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biochips Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biochips market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biochips ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biochips market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Deoxyribonucleic Acid (DNA) Chips; Protein Chips; Lab-On-Chip; Tissue Arrays; Cell Arrays
  • 2) By Technology: Microarrays; Microfluidics
  • 3) By Application: Drug Discovery And Development; Agriculture; Genomics; Disease Diagnostics; Proteomics; Other Applications
  • 4) By End-User: Biotechnology And Pharmaceutical Companies; Academic And Research Institutes; Hospitals And Diagnostic Centers; Other End-Users
  • Subsegments:
  • 1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips; Snp (Single Nucleotide Polymorphism) Chips; Dna Microarrays
  • 2) By Protein Chips: Antibody Arrays; Protein Microarrays; Peptide Arrays
  • 3) By Lab-On-Chip: Microfluidic Devices; Biosensors
  • 4) By Tissue Arrays: Tumor Tissue Arrays; Normal Tissue Arrays
  • 5) By Cell Arrays: Cell-Based Biochips; Cell Signaling Arrays
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics International Ltd; Zoetis Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Tecan Group Ltd.; Cepheid Inc.; Randox Laboratories Ltd.; Takara Bio Inc.; Oxford Nanopore Technologies plc; Luminex Corporation; Fluidigm Corporation; Micronit Microtechnologies B.V.; Sphere Fluidics Limited; Sengenics; Arrayit Corporation; CustomArray Inc.; Partek Incorporated; NanoCellect Biomedical Inc.; Dolomite Microfluidics; Biocartis NV
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biochips Market Characteristics

3. Biochips Market Trends And Strategies

4. Biochips Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biochips Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Biochips PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Biochips Market Growth Rate Analysis
  • 5.4. Global Biochips Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Biochips Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Biochips Total Addressable Market (TAM)

6. Biochips Market Segmentation

  • 6.1. Global Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid (DNA) Chips
  • Protein Chips
  • Lab-On-Chip
  • Tissue Arrays
  • Cell Arrays
  • 6.2. Global Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microarrays
  • Microfluidics
  • 6.3. Global Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Development
  • Agriculture
  • Genomics
  • Disease Diagnostics
  • Proteomics
  • Other Applications
  • 6.4. Global Biochips Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biotechnology And Pharmaceutical Companies
  • Academic And Research Institutes
  • Hospitals And Diagnostic Centers
  • Other End-Users
  • 6.5. Global Biochips Market, Sub-Segmentation Of Deoxyribonucleic Acid (DNA) Chips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Expression Chips
  • SNP (Single Nucleotide Polymorphism) Chips
  • DNA Microarrays
  • 6.6. Global Biochips Market, Sub-Segmentation Of Protein Chips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibody Arrays
  • Protein Microarrays
  • Peptide Arrays
  • 6.7. Global Biochips Market, Sub-Segmentation Of Lab-On-Chip, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microfluidic Devices
  • Biosensors
  • 6.8. Global Biochips Market, Sub-Segmentation Of Tissue Arrays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tumor Tissue Arrays
  • Normal Tissue Arrays
  • 6.9. Global Biochips Market, Sub-Segmentation Of Cell Arrays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell-Based Biochips
  • Cell Signaling Arrays

7. Biochips Market Regional And Country Analysis

  • 7.1. Global Biochips Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Biochips Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biochips Market

  • 8.1. Asia-Pacific Biochips Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biochips Market

  • 9.1. China Biochips Market Overview
  • 9.2. China Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biochips Market

  • 10.1. India Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biochips Market

  • 11.1. Japan Biochips Market Overview
  • 11.2. Japan Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biochips Market

  • 12.1. Australia Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biochips Market

  • 13.1. Indonesia Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biochips Market

  • 14.1. South Korea Biochips Market Overview
  • 14.2. South Korea Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biochips Market

  • 15.1. Western Europe Biochips Market Overview
  • 15.2. Western Europe Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biochips Market

  • 16.1. UK Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biochips Market

  • 17.1. Germany Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biochips Market

  • 18.1. France Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biochips Market

  • 19.1. Italy Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biochips Market

  • 20.1. Spain Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biochips Market

  • 21.1. Eastern Europe Biochips Market Overview
  • 21.2. Eastern Europe Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biochips Market

  • 22.1. Russia Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biochips Market

  • 23.1. North America Biochips Market Overview
  • 23.2. North America Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biochips Market

  • 24.1. USA Biochips Market Overview
  • 24.2. USA Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biochips Market

  • 25.1. Canada Biochips Market Overview
  • 25.2. Canada Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biochips Market

  • 26.1. South America Biochips Market Overview
  • 26.2. South America Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biochips Market

  • 27.1. Brazil Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biochips Market

  • 28.1. Middle East Biochips Market Overview
  • 28.2. Middle East Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biochips Market

  • 29.1. Africa Biochips Market Overview
  • 29.2. Africa Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biochips Market Competitive Landscape And Company Profiles

  • 30.1. Biochips Market Competitive Landscape
  • 30.2. Biochips Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biochips Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. QIAGEN N.V.
  • 31.4. Tecan Group Ltd.
  • 31.5. Cepheid Inc.
  • 31.6. Randox Laboratories Ltd.
  • 31.7. Takara Bio Inc.
  • 31.8. Oxford Nanopore Technologies plc
  • 31.9. Luminex Corporation
  • 31.10. Fluidigm Corporation
  • 31.11. Micronit Microtechnologies B.V.
  • 31.12. Sphere Fluidics Limited
  • 31.13. Sengenics
  • 31.14. Arrayit Corporation
  • 31.15. CustomArray Inc.

32. Global Biochips Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biochips Market

34. Recent Developments In The Biochips Market

35. Biochips Market High Potential Countries, Segments and Strategies

  • 35.1 Biochips Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Biochips Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Biochips Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer